Partner Fund Management »

Abivax SA F shares owned by Partner Fund Management

Quarter-by-quarter ownership of Abivax SA F (ABVX) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Abivax SA F

Tip: Access up to 7 years of quarterly data

All positions including Abivax SA F held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abivax SA F by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3M 32k 134.86

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
Eli Lilly & Co. (LLY)
Axsome Therapeutics (AXSM)
Centene Corporation (CNC)
Penumbra (PEN)
Ascendis Pharma A/s Sponsored Adr (ASND)
United Therapeutics Corporation (UTHR)
Bridgebio Pharma (BBIO)
Adma Biologics (ADMA)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Thermo Fisher Scientific (TMO)
Edwards Lifesciences (EW)
Icon SHS (ICLR)
Inhibrx Biosciences (INBX)

View all positions for Partner Fund Management

Top funds holding Abivax SA F

TCG Crossover Management
UBS Group
Darwin Global Management
Point72 Asset Management
Vestal Point Capital
Susquehanna International
Caligan Partners
Paradigm Biocapital Advisors
FMR
Cormorant Asset Management
ADAR1 Capital Management
Barclays
Citadel Advisors
Westfield Capital Management Company
Baker Bros. Advisors

View all funds holding Abivax SA F